InnoCan Pharma Corporation
INNO
Peringkat dalam Saham
#33902
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Harga Saham
$1.39
Terakhir disinkronkan: 2026-10-15
Kapitalisasi Pasar
$6.27M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-88.85%
Negara
CA
Perdagangan InnoCan Pharma Corporation (INNO)
Kategori
Healthcare
EPS untuk InnoCan Pharma Corporation (INNO)
EPS per 2026 TTM: 0
Menurut laporan keuangan terbaru dan harga saham InnoCan Pharma Corporation, EPS perusahaan saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki EPS sebesar 0 sama dengan EPS tahun 2026 sebesar 0.
Riwayat EPS untuk InnoCan Pharma Corporation dari 2026 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
